Bentoquatam
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Bentoquatam is a Protectant, Dermatological that is FDA approved for the prevention of poison ivy, oak and sumac rash when applied before exposure. Common adverse reactions include erythema.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
- Helps prevent poison ivy, oak and sumac rash when applied before exposure.
Dosage
Directions
- Shake well before use
- apply 15 minutes before risk exposure
- avoid intentional contact with poison ivy, oak and sumac
- adults and children 6 and older: apply every 4 hours for continued protection or sooner if needed
- children under 6 years: ask a doctor
- remove with soap and water after risk of exposure
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Bentoquatam in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Bentoquatam in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
There is limited information regarding FDA-Labeled Use of Bentoquatam in pediatric patients.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Bentoquatam in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Bentoquatam in pediatric patients.
Contraindications
- Hypersensitivity to bentoquatam and any components of the products such as methylparabens
Warnings
- For external use only. Flammable: keep away from fire or flame.
- Do not use: if you are allergic to any ingredients, on open rash. When using this product: do not get into eyes. If contact occurs, rinse eyes thoroughly with water.
- Keep out of reach of children.
- If swallowed, get medical help or contact a Poison Control Center right away.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Clinical Trial Experience of Bentoquatam in the drug label.
Postmarketing Experience
There is limited information regarding Postmarketing Experience of Bentoquatam in the drug label.
Drug Interactions
There is limited information regarding Bentoquatam Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
Pregnancy Category (FDA):
There is no FDA guidance on usage of Bentoquatam in women who are pregnant.
Pregnancy Category (AUS):
- Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Bentoquatam in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Bentoquatam during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Bentoquatam with respect to nursing mothers.
Pediatric Use
There is no FDA guidance on the use of Bentoquatam with respect to pediatric patients.
Geriatic Use
There is no FDA guidance on the use of Bentoquatam with respect to geriatric patients.
Gender
There is no FDA guidance on the use of Bentoquatam with respect to specific gender populations.
Race
There is no FDA guidance on the use of Bentoquatam with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Bentoquatam in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Bentoquatam in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Bentoquatam in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Bentoquatam in patients who are immunocompromised.
Administration and Monitoring
Administration
- Topical Lotion
Monitoring
There is limited information regarding Monitoring of Bentoquatam in the drug label.
IV Compatibility
There is limited information regarding IV Compatibility of Bentoquatam in the drug label.
Overdosage
There is limited information regarding Chronic Overdose of Bentoquatam in the drug label.
Pharmacology
There is limited information regarding Bentoquatam Pharmacology in the drug label.
Mechanism of Action
There is limited information regarding Bentoquatam Mechanism of Action in the drug label.
Structure
Pharmacodynamics
There is limited information regarding Pharmacodynamics of Bentoquatam in the drug label.
Pharmacokinetics
There is limited information regarding Pharmacokinetics of Bentoquatam in the drug label.
Nonclinical Toxicology
There is limited information regarding Nonclinical Toxicology of Bentoquatam in the drug label.
Clinical Studies
There is limited information regarding Clinical Studies of Bentoquatam in the drug label.
How Supplied
There is limited information regarding Bentoquatam How Supplied in the drug label.
Storage
There is limited information regarding Bentoquatam Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Bentoquatam |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Bentoquatam |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Patient Counseling Information of Bentoquatam in the drug label.
Precautions with Alcohol
- Alcohol-Bentoquatam interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
There is limited information regarding Bentoquatam Brand Names in the drug label.
Look-Alike Drug Names
There is limited information regarding Bentoquatam Look-Alike Drug Names in the drug label.
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
{{#subobject:
|Page Name=Bentoquatam
|Pill Name=No image.jpg
|Drug Name=
|Pill Ingred=|+sep=;
|Pill Imprint=
|Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
|Pill Color=|+sep=;
|Pill Shape=
|Pill Size (mm)=
|Pill Scoring=
|Pill Image=
|Drug Author=
|NDC=
}}
{{#subobject:
|Label Page=Bentoquatam |Label Name=b01.png
}}
{{#subobject:
|Label Page=Bentoquatam |Label Name=b02.png
}}